Human Genome Sciences
Rockville · Founded 1992
About Human Genome Sciences
Human Genome Sciences is a biopharmaceutical research company that specializes in discovering and developing drugs based on human genomic information. It applies genomic data and bioinformatics to identify protein and antibody targets associated with diseases and advanced therapeutic candidates for conditions including autoimmune disorders, infectious diseases, and other complex health challenges. The company engages in collaborative research with other biotechnology and pharmaceutical organizations to progress clinical-stage programs and expand its development pipeline. Human Genome Sciences produces biologically derived molecules such as monoclonal antibodies and proteins intended for clinical testing, with some candidates progressing through advanced trials prior to regulatory review. Its work contributed to the development of therapies aimed at addressing diseases with unmet medical needs by leveraging gene-based discovery platforms and translational research approaches.
Company Facts
- Founded: 1992
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 10,001+
- Funding stage: M&A
- Last round: Series Unknown (May 2001)
- Website: hgsi.com
- Phone: 13013098504
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/human-genome-sciences-130888 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.